LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 74.50 | 770.25 | 9532 | 10991 | 0.8672 | 0.9271 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 74.50 | 770.25 | 8009 | 10991 | 0.7287 | 0.8415 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 76.75 | 770.25 | 9797 | 11262 | 0.8699 | 0.9292 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 76.75 | 770.25 | 8216 | 11262 | 0.7295 | 0.8435 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 78.98 | 770.25 | 10181 | 11518 | 0.8839 | 0.9377 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 78.98 | 770.25 | 8562 | 11518 | 0.7433 | 0.8536 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 81.20 | 770.25 | 10594 | 11766 | 0.9004 | 0.9473 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 81.20 | 770.25 | 8733 | 11766 | 0.7422 | 0.8540 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 83.42 | 770.25 | 10905 | 12031 | 0.9063 | 0.9510 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 83.42 | 770.25 | 8982 | 12031 | 0.7465 | 0.8579 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 85.64 | 770.25 | 11365 | 12287 | 0.9249 | 0.9613 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 85.64 | 770.25 | 9260 | 12287 | 0.7536 | 0.8633 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 87.86 | 770.25 | 11646 | 12543 | 0.9285 | 0.9635 | MN20160304_L02 | K19 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.056667 | 87.86 | 770.25 | 9451 | 12543 | 0.7535 | 0.8642 | MN20160304_L02 | N06 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 3.21 | 770.25 | 795 | 904 | 0.8788 | 0.1461 | MN20160304_L02 | F11 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 3.21 | 770.25 | 969 | 904 | 1.0712 | 1.6898 | MN20160304_L02 | M16 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 5.44 | 770.25 | 842 | 1012 | 0.8314 | 0.2530 | MN20160304_L02 | F11 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 5.44 | 770.25 | 1074 | 1012 | 1.0605 | 1.3207 | MN20160304_L02 | M16 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 7.66 | 770.25 | 920 | 1090 | 0.8440 | 0.4257 | MN20160304_L02 | F11 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 7.66 | 770.25 | 1178 | 1090 | 1.0807 | 1.3353 | MN20160304_L02 | M16 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 10.06 | 770.25 | 1022 | 1218 | 0.8387 | 0.5332 | MN20160304_L02 | F11 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 10.06 | 770.25 | 1303 | 1218 | 1.0693 | 1.2133 | MN20160304_L02 | M16 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 12.28 | 770.25 | 1085 | 1358 | 0.7989 | 0.5201 | MN20160304_L02 | F11 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 12.28 | 770.25 | 1409 | 1358 | 1.0375 | 1.0919 | MN20160304_L02 | M16 |
| MCF 10A-H2B-mCherry | Palbociclib | 0.1 | 14.50 | 770.25 | 1146 | 1497 | 0.7654 | 0.5134 | MN20160304_L02 | F11 |